Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | -5.11% | -10.22% | +43.97% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.97% | 405M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-1.86% | 21.66B | |
-18.35% | 20.77B | |
-8.56% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics : Plummets Following Interim Phase 1 Ovarian Cancer Trial Data